Peter Langguth is Professor at the Department of Pharmaceutical Technology and Biopharmaceutics at Johannes Gutenberg University, Mainz, Germany and Head of the APV Focus Group Biopharmaceutics and Pharmacokinetics.
The New EMA Bioequivalence Guideline: Key Considerations
A new guideline for conducting bioequivalence studies was adopted by the CPMP in January and it becomes fully effective as of August 2010.